Menu
Neurology

Dopa-Responsive Dystonia (Segawa Disease)

ICD-10 Code
G24.09

Clinical Criteria for Dopa-Responsive Dystonia (Segawa Disease).

Clinical Presentation & Protocol

Patient Usually Complains Of

Patient presents with a history of progressive gait disturbance, typically manifesting as lower limb dystonia. Symptoms exhibit characteristic diurnal fluctuation, with worsening of motor symptoms toward the evening and significant improvement following sleep. Onset typically in childhood with foot dystonia or equinovarus posturing. No history of cognitive decline or significant parkinsonism at rest.

Clinical Examination Findings

General physical examination is unremarkable for systemic disease. Vital signs are stable. No evidence of hepatosplenomegaly, dysmorphic features, or skin lesions suggestive of neurocutaneous syndromes. Growth parameters are within normal limits.

Treatment Protocol

Initiate low-dose Levodopa/Carbidopa (e.g., 50-100 mg/day). Monitor for immediate and sustained clinical response. Titrate dose slowly to achieve optimal motor function with minimal side effects. Long-term maintenance therapy is required. Periodic reassessment of dosage is necessary to manage potential fluctuations.

Detailed clinical guide coming soon.